CSP
9 min read
52

Bioretec Ltd’s business review January–September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage

November 14, 2024
0

Reading Time: 7 minutes Bioretec Ltd  Company announcement 14 November 2024 at 8:45 a.m. This announcement summarizes Bioretec Ltd’s business review for January–September 2024. The complete business review is attached to this release as a PDF file and available on the company’s website at https://bioretec.com/investors/investors-in-english/releases.   July

Continue Reading
E-Commerce AI Startup BiteSpeed Raises USD 3.5M Funding, Led by Peak XV’s Surge
BWI
4 min read
32

E-Commerce AI Startup BiteSpeed Raises USD 3.5M Funding, Led by Peak XV’s Surge

November 14, 2024
0

Reading Time: 3 minutes Bangalore, Karnataka, India:    This brings BiteSpeed’s total capital raised to $5.6M, following two previous rounds: a $1.9M round led by Peak XV’s Surge and a $275K round led by Whiteboard Capital. The E-commerce AI startup also has more than

Continue Reading
FedEx Economic Impact Report Showcases ‘FedEx Effect’ on Driving India’s Growth and Commitment to Sustainability
NV
4 min read
72

FedEx Economic Impact Report Showcases ‘FedEx Effect’ on Driving India’s Growth and Commitment to Sustainability

November 14, 2024
0

Reading Time: 3 minutes FedEx Corp. (NYSE: FDX) released its annual economic impact report, analyzing the company’s worldwide network and role in building prosperity in local communities during its 2024 fiscal year (FY 2024). Produced in consultation with Dun & Bradstreet (NYSE: DNB), a leading provider of business decisioning

Continue Reading
CSP
2 min read
16

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

November 14, 2024
0

Reading Time: 2 minutes DecideAct A/S [ACT] Company Announcement No. 10-2024: NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies

Continue Reading
CSP
2 min read
10

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

November 14, 2024
0

Reading Time: 2 minutes DecideAct A/S [ACT] NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies and wants to

Continue Reading
Andersen Global Adds M&A and Investment Banking Capabilities to Platform in South Africa
BWI
2 min read
31

Andersen Global Adds M&A and Investment Banking Capabilities to Platform in South Africa

November 14, 2024
0

Reading Time: 2 minutes San Francisco, United States:   Andersen Global continues to build its multidisciplinary platform in South Africa through a Collaboration Agreement with Merchantec Capital, an M&A and investment banking firm based in Johannesburg.   Operating for over two decades, Merchantec Capital

Continue Reading
Tecnotree Selected to Provide Multi-Tenant MVNE Platform and Moments Marketplace to Power Tier 1 MVNE in EMEA
BWI
3 min read
32

Tecnotree Selected to Provide Multi-Tenant MVNE Platform and Moments Marketplace to Power Tier 1 MVNE in EMEA

November 14, 2024
0

Reading Time: 2 minutes Espoo, Finland:   Tecnotree, a global digital Business Support Systems (BSS) provider and a leader in digital transformation solutions, has announced its latest collaboration with a leading MVNE in EMEA. This partnership will harness the multi-tenant capabilities of Tecnotree’s state-of-the-art MVNE platform

Continue Reading
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
BWI
4 min read
34

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen

November 14, 2024
0

Reading Time: 3 minutes MUMBAI, India & HYDERABAD, India:  PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part

Continue Reading
MilDef completes a directed share issue of approximately 5.4 million shares, raising proceeds of SEK 500 million
CSP
16 min read
14

MilDef completes a directed share issue of approximately 5.4 million shares, raising proceeds of SEK 500 million

November 13, 2024
0

Reading Time: 11 minutes MilDef Group AB (publ) (“MilDef” or the “Company”) has successfully carried out a directed share issue of 5,434,782 shares at a subscription price of SEK 92 per share (the “Directed Share Issue”). As a result of the strong demand from both

Continue Reading
ABS Wavesight eLogs Selected by Noble Corporation for Offshore Digital Recordkeeping, Expanding Adoption Across Entire Fleet
CSP
3 min read
9

ABS Wavesight eLogs Selected by Noble Corporation for Offshore Digital Recordkeeping, Expanding Adoption Across Entire Fleet

November 13, 2024
0

Reading Time: 2 minutes (HOUSTON) — ABS Wavesight has partnered with Noble Corporation, a leading offshore drilling contractor, to revolutionize its recordkeeping practices by adopting ABS Wavesight eLogs™ electronic logbooks on its entire fleet of offshore assets. This collaboration marks a major milestone for offshore

Continue Reading